Data from Noninvasive <i>De novo</i> Imaging of Human Embryonic Stem Cell–Derived Teratoma Formation

Feng Cao,Zibo Li,Andrew Lee,Zhaofei Liu,Kai Chen,Hui Wang,Weibo Cai,Xiaoyuan Chen,Joseph C. Wu
DOI: https://doi.org/10.1158/0008-5472.c.6499539
2023-01-01
Abstract:<div>Abstract<p>Teratoma formation can be a serious drawback after the therapeutic transplantation of human embryonic stem (hES) cells. Therefore, noninvasive imaging of teratomas could be a valuable tool for monitoring patients undergoing hES cell treatment. Here, we investigated the angiogenic process within teratomas derived from hES cells and now report the first example of using <sup>64</sup>Cu-labeled RGD tetramer (<sup>64</sup>Cu-DOTA-RGD4) for positron emission tomography imaging of teratoma formation by targeting α<sub>v</sub>β<sub>3</sub> integrin. H9 hES cells (2 × 10<sup>6</sup>), stably expressing firefly luciferase, and enhanced green fluorescence protein (Fluc-eGFP) were injected into adult nude mice (<i>n</i> = 12) s.c. Eight weeks after transplantation, these hES cell grafts evolved into teratomas as confirmed by longitudinal bioluminescence imaging. Under micropositron emission tomography imaging, 2-deoxy-2-[<sup>18</sup>F]fluoro-D-glucose and 3′-deoxy-3′-[<sup>18</sup>F]-fluorothymidine both failed to detect hES cell–derived teratomas (0.8 ± 0.5 versus 1.1 ± 0.4 %ID/g, respectively; <i>P</i> = not significant versus background signals). By contrast, <sup>64</sup>Cu-DOTA-RGD4 revealed specific and prominent uptake in vascularized teratoma and significantly lower uptake in control tumors (human ovarian carcinoma 2008 cell line), which had low intergrin expression (10.1 ± 3.4 versus 1.4 ± 1.2 %ID/g; <i>P</i> < 0.01). Immunofluorescence staining of CD31 and β<sub>3</sub> integrin also supported our <i>in vivo</i> imaging results (<i>P</i> < 0.05). Moreover, we found that the cells dissociated from teratomas showed higher α<sub>v</sub>β<sub>3</sub> integrin expression than the 2008 cells. In conclusion, by targeting α<sub>v</sub>β<sub>3</sub> integrin, we successfully showed the ability of <sup>64</sup>Cu-DOTA-RGD4 to noninvasively visualize teratoma formation <i>in vivo</i> for the first time. [Cancer Res 2009;69(7):2709–13]</p></div>
What problem does this paper attempt to address?